Note to users. If you're seeing this message, it means that your browser cannot find this page's style/presentation instructions -- or possibly that you are using a browser that does not support current Web standards. Find out more about why this message is appearing, and what you can do to make your experience of our site the best it can be.

Originally published in Science Express on 25 October 2007
Science 23 November 2007:
Vol. 318. no. 5854, pp. 1309 - 1312
DOI: 10.1126/science.1146157
Prev | Table of Contents | Next

Reports

Hold Your Horses: Impulsivity, Deep Brain Stimulation, and Medication in Parkinsonism

Michael J. Frank,1* Johan Samanta,2,3 Ahmed A. Moustafa,1 Scott J. Sherman3

Deep brain stimulation (DBS) of the subthalamic nucleus markedly improves the motor symptoms of Parkinson's disease, but causes cognitive side effects such as impulsivity. We showed that DBS selectively interferes with the normal ability to slow down when faced with decision conflict. While on DBS, patients actually sped up their decisions under high-conflict conditions. This form of impulsivity was not affected by dopaminergic medication status. Instead, medication impaired patients' ability to learn from negative decision outcomes. These findings implicate independent mechanisms leading to impulsivity in treated Parkinson's patients and were predicted by a single neurocomputational model of the basal ganglia.

1 Department of Psychology and Program in Neuroscience, University of Arizona, Tucson, AZ 85721, USA.
2 Banner Good Samaritan Medical Center, Phoenix, AZ 85004, USA.
3 Department of Neurology, University of Arizona, Tucson, AZ 85724, USA.

* To whom correspondence should be addressed. E-mail: mfrank{at}u.arizona.edu

Read the Full Text


THIS ARTICLE HAS BEEN CITED BY OTHER ARTICLES:
Parkinson's disease, DBS and suicide: a role for serotonin?.
Y. Temel, S. Tan, V. Visser-Vandewalle, and T. Sharp (2009)
Brain 132, e126
   Full Text »    PDF »
Reward-learning and the novelty-seeking personality: a between- and within-subjects study of the effects of dopamine agonists on young Parkinson's patients.
N. Bodi, S. Keri, H. Nagy, A. Moustafa, C. E. Myers, N. Daw, G. Dibo, A. Takats, D. Bereczki, and M. A. Gluck (2009)
Brain 132, 2385-2395
   Abstract »    Full Text »    PDF »
Anaesthesia for deep brain stimulation and in patients with implanted neurostimulator devices.
C. C. M. Poon and M. G. Irwin (2009)
Br. J. Anaesth. 103, 152-165
   Abstract »    Full Text »    PDF »
Encoding of Marginal Utility across Time in the Human Brain.
A. Pine, B. Seymour, J. P. Roiser, P. Bossaerts, K. J. Friston, H. V. Curran, and R. J. Dolan (2009)
J. Neurosci. 29, 9575-9581
   Abstract »    Full Text »    PDF »
The scientific and clinical basis for the treatment of Parkinson disease (2009).
C. W. Olanow, M. B. Stern, and K. Sethi (2009)
Neurology 72, S1-S136
   Abstract »    Full Text »    PDF »
Stimulating brains, altering minds.
W Glannon (2009)
J. Med. Ethics 35, 289-292
   Abstract »    Full Text »    PDF »
Subthalamic Nucleus Stimulation in Severe Obsessive-Compulsive Disorder.
M. Dettling, I.-G. Anghelescu, S. Kapoor, M.-L. Welter, A. Pelissolo, L. Mallet, and the STOC Study Group (2009)
N. Engl. J. Med. 360, 931-932
   Full Text »    PDF »
CNTRICS Final Task Selection: Long-Term Memory.
J. D. Ragland, R. Cools, M. Frank, D. A. Pizzagalli, A. Preston, C. Ranganath, and A. D. Wagner (2009)
Schizophr Bull 35, 197-212
   Abstract »    Full Text »    PDF »
A Role for Dopamine in Temporal Decision Making and Reward Maximization in Parkinsonism.
A. A. Moustafa, M. X. Cohen, S. J. Sherman, and M. J. Frank (2008)
J. Neurosci. 28, 12294-12304
   Abstract »    Full Text »    PDF »
Subthalamic Nucleus Stimulation in Severe Obsessive-Compulsive Disorder.
L. Mallet, M. Polosan, N. Jaafari, N. Baup, M.-L. Welter, D. Fontaine, S. T. d. Montcel, J. Yelnik, I. Chereau, C. Arbus, et al. (2008)
N. Engl. J. Med. 359, 2121-2134
   Abstract »    Full Text »    PDF »
Schizophrenia: A Computational Reinforcement Learning Perspective.
M. J. Frank (2008)
Schizophr Bull 34, 1008-1011
   Full Text »    PDF »
A multicentre study on suicide outcomes following subthalamic stimulation for Parkinson's disease.
V. Voon, P. Krack, A. E. Lang, A. M. Lozano, K. Dujardin, M. Schupbach, J. D'Ambrosia, S. Thobois, F. Tamma, J. Herzog, et al. (2008)
Brain 131, 2720-2728
   Abstract »    Full Text »    PDF »
Attempted and completed suicides after subthalamic nucleus stimulation for Parkinson's disease.
T Soulas, J-M Gurruchaga, S Palfi, P Cesaro, J-P Nguyen, and G Fenelon (2008)
J. Neurol. Neurosurg. Psychiatry 79, 952-954
   Abstract »    Full Text »    PDF »
Parkinson's disease and dopaminergic therapy--differential effects on movement, reward and cognition.
J. B. Rowe, L. Hughes, B. C. P. Ghosh, D. Eckstein, C. H. Williams-Gray, S. Fallon, R. A. Barker, and A. M. Owen (2008)
Brain 131, 2094-2105
   Abstract »    Full Text »    PDF »
Comment on "Genetically Determined Differences in Learning from Errors".
M. Lucht and D. Rosskopf (2008)
Science 321, 200a
   Abstract »    Full Text »    PDF »
Role for Subthalamic Nucleus Neurons in Switching from Automatic to Controlled Eye Movement.
M. Isoda and O. Hikosaka (2008)
J. Neurosci. 28, 7209-7218
   Abstract »    Full Text »    PDF »


To Advertise     Find Products

Science. ISSN 0036-8075 (print), 1095-9203 (online)